MedXtractor Corp. Reports Financial Results for Year Ended February 29, 2020

Calgary, Alberta--(Newsfile Corp. - May 19, 2020) - MedXtractor Corp. (CSE: MXT) ("MXT" or the "Corporation") announces its financial results for the year ended February 29, 2020.

MXT had positive cash flows from operations of $92,117 and incurred a net loss of $36,598 for the year ended February 29, 2020. On February 29, 2020, MXT had working capital of $629,909 including cash of $594,492 as compared to working capital of $235,377 including cash of $143,489 as at February 28, 2019. The Corporation has no debt and no material liabilities.

Mr. Jim Durward, CEO, states "Despite a challenging operating environment and significant one-time costs associated with the going-public process, we managed to remain cash-flow positive for the period. This result was due to strict adherence to our low-fixed-cost operating model, a targeted marketing effort, and the continuing trend toward worldwide cannabis legalization. Despite the positive nature of our operations, our share price has not escaped the overall depressed state of the entire cannabis complex and at our current market capitalization of less than $2,000,000, I believe that MXT is significantly undervalued; a situation we intend to address by increasing our visibility to cannabis investors. Going forward we will seek to increase shareholder value from a stronger marketing presence, internal product development and posibly mergers and acquisitions. I also thank our shareholders for their patience and continuing support as we work through this extraordinary environment."

ABOUT MEDXTRACTOR CORP:

The Corporation is a Calgary-based company that manufactures patented, proprietary craft-scale carbon dioxide-based extractors that are used to extract essential oils and compounds from a variety of botanical materials. Growing demand is from the premium craft medical cannabis market as these growers respond to the shift toward high-purity oils and concentrates as the base for a multitude of products such as vapes, dabs, edibles, tinctures, sprays, and suppositories. The ongoing worldwide cannabis legalization movement is expected to further increase demand for extracts and the Corporation has installations in multiple countries worldwide. The Corporation owns the US patent, and the Canadian Patent application, on its CO2-based extraction process.

FOR FURTHER INFORMATION, PLEASE CONTACT:

MEDXTRACTOR CORP.
James M. Durward, President and CEO
Telephone: (403) 689-3901
Email: jimd@medxtractor.com
Website: www.medxtractor.com

This news release does not constitute an offer to sell or a solicitation of an offer to sell any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.

The information in this news release includes certain information and statements about management's view of future events, expectations, plans and prospects that constitute forward looking statements. These statements are based upon assumptions that are subject to significant risks and uncertainties. Because of these risks and uncertainties and as a result of a variety of factors, the actual results, expectations, achievements or performance may differ materially from those anticipated and indicated by these forward looking statements. Any number of factors could cause actual results to differ materially from these forward-looking statements as well as future results. Although the Corporation believes that the expectations reflected in forward looking statements are reasonable, it can give no assurances that the expectations of any forward-looking statements will prove to be correct. Except as required by law, the Corporation disclaims any intention and assumes no obligation to update or revise any forward looking statements to reflect actual results, whether as a result of new information, future events, changes in assumptions, changes in factors affecting such forward looking statements or otherwise.

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/56098

info